Literature DB >> 18699966

Exogenous bone marrow cells do not rescue non-irradiated mice from acute renal tubular damage caused by HgCl2, despite establishment of chimaerism and cell proliferation in bone marrow and spleen.

T-C Fang1, W R Otto, R Jeffery, T Hunt, M R Alison, H T Cook, N A Wright, R Poulsom.   

Abstract

OBJECTIVE: Various studies have shown that bone marrow stem cells can rescue mice from acute renal tubular damage under a conditioning advantage (irradiation or cisplatin treatment) favouring donor cell engraftment and regeneration; however, it is not known whether bone marrow cells (BMCs) can contribute to repair of acute tubular damage in the absence of a selection pressure for the donor cells. The aim of this study was to examine this possibility.
MATERIALS AND METHODS: Ten-week-old female mice were assigned into control non-irradiated animals having only vehicle treatment, HgCl(2)-treated non-irradiated mice, HgCl(2)-treated non-irradiated mice infused with male BMCs 1 day after HgCl(2), and vehicle-treated mice with male BMCs. Tritiated thymidine was given 1 h before animal killing.
RESULTS: Donor BMCs could not alleviate non-irradiated mice from acute tubular damage caused by HgCl(2), deduced by no reduction in serum urea nitrogen combined with negligible cell engraftment. However, donor BMCs could home to the bone marrow and spleen and display proliferative activity. This is the first report to show that despite no preparative myeloablation of recipients, engrafted donor BMCs can synthesize DNA in the bone marrow and spleen.
CONCLUSIONS: Exogenous BMCs do not rescue non-irradiated mice from acute renal tubular damage caused by HgCl(2), despite establishment of chimerism and cell proliferation in bone marrow and spleen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18699966      PMCID: PMC6495886          DOI: 10.1111/j.1365-2184.2008.00546.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  47 in total

Review 1.  Biology and clinical applications of mesenchymal stem cells.

Authors:  Frank P Barry
Journal:  Birth Defects Res C Embryo Today       Date:  2003-08

Review 2.  Plasticity of marrow-derived stem cells.

Authors:  Erica L Herzog; Li Chai; Diane S Krause
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

3.  Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model.

Authors:  S K Nilsson; M S Dooner; C Y Tiarks; H U Weier; P J Quesenberry
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

4.  Proliferation of donor spleen and bone-marrow cells in the spleens and bone marrows of unirradiated and irradiated adult mice.

Authors:  A Takada; Y Takada; J L Ambrus
Journal:  Proc Soc Exp Biol Med       Date:  1971-01

5.  Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria I D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong J Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

6.  High levels of engraftment with a single infusion of bone marrow cells into normal unprepared mice.

Authors:  H S Ramshaw; R B Crittenden; M Dooner; S O Peters; S S Rao; P J Quesenberry
Journal:  Biol Blood Marrow Transplant       Date:  1995-12       Impact factor: 5.742

7.  Homing of fluorescently labeled murine hematopoietic stem cells.

Authors:  P J Hendrikx; C M Martens; A Hagenbeek; J F Keij; J W Visser
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

8.  Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice.

Authors:  Norman Ende; Ruifeng Chen; Alluru S Reddi
Journal:  Biochem Biophys Res Commun       Date:  2004-08-13       Impact factor: 3.575

9.  Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke.

Authors:  Cesar V Borlongan; Martin Hadman; Cyndy Davis Sanberg; Paul R Sanberg
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

10.  Some effects of chemotherapeutic drugs. III. Short- and long-term effects of cis-platinum on various hematopoietic compartments and on the kidney of the mouse.

Authors:  D Dumenil; D Droz; J P Droz; E Frindel
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

View more
  4 in total

1.  Hematopoietic stem cells derived from human umbilical cord ameliorate cisplatin-induced acute renal failure in rats.

Authors:  Rokaya H Shalaby; Laila A Rashed; Alaa E Ismaail; Naglaa K Madkour; Sherien H Elwakeel
Journal:  Am J Stem Cells       Date:  2014-09-05

2.  Proliferation of myofibroblasts in the stroma of renal oncocytoma.

Authors:  T-H Yen; Y Chen; J-F Fu; C-H Weng; Y-C Tian; C-C Hung; J-L Lin; C-W Yang
Journal:  Cell Prolif       Date:  2010-04-14       Impact factor: 6.831

Review 3.  Regeneration and bioengineering of the kidney: current status and future challenges.

Authors:  Marcus Salvatori; Andrea Peloso; Ravi Katari; Giuseppe Orlando
Journal:  Curr Urol Rep       Date:  2014-01       Impact factor: 3.092

4.  Bone marrow cells contribute to tubular epithelium regeneration following acute kidney injury induced by mercuric chloride.

Authors:  Neelam Yadav; Someshwara Rao; Dipankar M Bhowmik; Asok Mukhopadhyay
Journal:  Indian J Med Res       Date:  2012-08       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.